Mov Disord Vol 31, Suppl 2 Archives - Page 70 of 207 - MDS Abstracts

2016 International Congress
Neuromelanin in Parkinson’s disease: A 3 T MRI study
S. Pietracupa, A. Martin-Bastida, N.L. Kaim, S. Schwarz, D. Auer, A. Berardelli, P. Piccini (Rome, Italy)
Objective: The purpose of this study was to investigate whether the signal intensity of the substantia nigra pars compacta (SNc) and locus coeruleus (LC) on…
2016 International Congress
Disrupted hubs in functional brain networks in subtype-specific Parkinson’s disease
L. Ma, H. Chen, T. Feng (Beijing, People's Republic of China)
Objective: To detect the changing pattern in functional network hubs in subtype-specific Parkinson's disease (PD) using resting-state functional magnetic resosonce imaging (Rs-fMRI). Background: PD is…
2016 International Congress
Increasing placebo response in Parkinson’s disease through apomorphine pre-conditioning
E. Frisaldi, E. Carlino, L. Giudetti, A. Pampallona, M. Zibetti, M. Lanotte, L. Lopiano, F. Benedetti (Turin, Italy)
Objective: To see whether a placebo response requires pharmacological pre-conditioning with apomorphine. Background: Placebos have been found to affect the patient's brain in a number…
2016 International Congress
Olfactory performance and resting state functional connectivity in non-demented drug naïve patients with Parkinson’s disease
M. Sunwoo, J.H. Ham, J.Y. Hong, Y.H. Sohn, P.H. Lee (Seongnam, Korea)
Objective: We investigated the pattern of resting state functional connectivity in patients with PD according to olfactory performance to elucidate olfactory-dependent cortical-subcortical functional networks. Background:…
2016 International Congress
Functional connectome organization is altered in PD patients with mild cognitive impairment
S. Galantucci, F. Agosta, I. Stankovic, S. Basaia, T. Stojkovic, E. Stefanova, E. Canu, A. Meani, V.S. Kostic, M. Filippi (Milan, Italy)
Objective: The aim of the study was to investigate the functional brain connectome organization in patients with Parkinson's disease (PD) with mild cognitive impairment (MCI).…
2016 International Congress
The relationship among clinical features, DAT scintigraphy and MIBG cardiac scintigraphy in patients with Parkinson’s disease
J. Ebina, T. Sekiguchi, M. Takahashi, A. Inaba, S. Orimo (Tokyo, Japan)
Objective: The aim of this study is to evaluate correlations among clinical features of Parkinson's disease (PD), odor stick identification test for Japanese (OSIT-J) score,…
2016 International Congress
In vivo MRI detection of Parkinson’s disease associated degeneration in the lateral ventral tier of substantia nigra pars compacta
D.E. Huddleston, J. Langley, J. Sedlacik, K. Boelmans, S.A. Factor, X. Hu (Atlanta, GA, USA)
Objective: To test a novel multimodal MRI approach for in vivo assessment of the subregion of substantia nigra pars compacta (SNpc) most vulnerable to Parkinson's…
2016 International Congress
Comparison of Test Your Memory (TYM) and Montreal Cognitive Assessment (MoCA) measures in Parkinson’s disease
E.J. Henderson, H. Chu, D.M. Gaunt, A.L. Whone, Y. Ben-Shlomo, V. Lyell (Bristol, United Kingdom)
Objective: We sought to determine: a) the ability of TYM to discriminate between PD patients with and without cognitive deficits b) equivalence between MoCA scores…
2016 International Congress
Cognitive and behavioral problems in children and adolescents with myoclonus dystonia
M.A. Coenen, H. Eggink, H. van den Berg, J.M. Spikman, M.A. Tijssen (Groningen, Netherlands)
Objective: To compare the neuropsychological and behavioral profile of A) children and adolescents with myoclonus dystonia (MD) to a healthy control group and B) MD…
2016 International Congress
Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia
R.R. Umarov, N.G. Sokhibnazarov (Tashkent, Uzbekistan)
Objective: To study the value of various neuropsychological scales to determine the degree of cognitive dysfunction in patients with posttraumatic subcortical Parkinsonian dementia, during the…